Introduction
============

Psychological distress, accompanied by altered fluctuations in the sympathetic nervous system, is often considered a component of an increased cardiovascular risk.[@b1-ndt-13-2093]--[@b3-ndt-13-2093] Individuals with an increased baseline activity of sympathetic system and sympathetic nervous system hyperresponsivity might be at an elevated risk for increased blood pressure (BP) if the "balance" among factors is missing.[@b1-ndt-13-2093],[@b4-ndt-13-2093]--[@b11-ndt-13-2093]

A higher hypertension prevalence in individuals with the depressive disorder has been found by Adamis and Ball[@b12-ndt-13-2093] and Nakagawara et al.[@b13-ndt-13-2093] Shinagawa et al[@b14-ndt-13-2093] showed that a depressive affectivity is related to increased levels of the BP in a 1-week monitoring of 54 patients. The increased frequency of depressive symptoms has been shown in patients with hypertension as well.[@b15-ndt-13-2093] There are also data showing an abnormal reactivity of the autonomic nervous system (ANS) in depression, specifically regarding the elevated sympathetic activity and a poor parasympathetic control.[@b16-ndt-13-2093]--[@b18-ndt-13-2093]

Emotional distress stimulates the sympathetic activity producing fluctuations in the cardiovascular system -- tachycardia, hypertension, and relocation of the blood flow. The cardiovascular system control is particularly sensitive to the ANS governing stimuli.[@b1-ndt-13-2093],[@b19-ndt-13-2093],[@b20-ndt-13-2093] The frequency of the heart beat constantly fluctuates to adapt to the changes in cardiovascular variables such as respiration, BP, body temperature, and so on. Heart rate variability (HRV) has been shown to depend on the mechanisms of control mediated by the sympathetic and parasympathetic nervous systems and their interaction with each other.[@b21-ndt-13-2093] The ANS leads messages through the sympathetic and parasympathetic nervous systems. Sympathetic and parasympathetic partitions function antagonistically to preserve a dynamic modulation of vital functions.[@b21-ndt-13-2093] These systems act through the stellar ganglion and the vagus nerve. The interaction of these messages toward the sinoauricular node is responsible for normal cardiac variability, which can be assessed by monitoring HRV. HRV is a measure of cardiac autonomic function. The most frequently used HRV parameters in ANS evaluation are the frequency domain, time domain, and Poincaré plot factors.[@b22-ndt-13-2093]--[@b24-ndt-13-2093] Frequency domain analysis defines variations of low- and high-frequency variability that relate to the activity of the different ANS branches. By using these frequency ranges in HRV, investigators can separate the sympathetic and parasympathetic systems.[@b22-ndt-13-2093],[@b24-ndt-13-2093]

Heart rate (HR) is primarily regulated by a vagal activity,[@b22-ndt-13-2093] and this is an indicator of both how the central nervous system (CNS) controls the ANS and how peripheral neurons feed information back to the CNS.[@b23-ndt-13-2093],[@b24-ndt-13-2093] Appropriate work of the sympathetic/parasympathetic dynamic equilibrium at rest as well as in reaction to distress allows the adaptive answer to environment -- allostasis.[@b4-ndt-13-2093],[@b25-ndt-13-2093] On the other hand, a lack of flexibility can lead to physical and psychological pathologies.[@b24-ndt-13-2093],[@b26-ndt-13-2093] The sympathetic hyperactivity accompanying parasympathetic hypoactivity could characterize potential pathological mechanism causing the heightened risk of not only a cardiovascular pathology but also depression and anxiety disorders.[@b21-ndt-13-2093],[@b27-ndt-13-2093]--[@b30-ndt-13-2093] Reduced HRV reflects amplified sympathetic activity and decreased parasympathetic activity in depressive patients.[@b31-ndt-13-2093]--[@b36-ndt-13-2093] and also in anxious patients and would reflect a deficit in the flexibility of emotional and physiological mechanisms.[@b24-ndt-13-2093] Reduced findings in HRV reflect a changed sympathovagal equilibrium of the sinoatrial node. This different equilibrium is characterized by a sympathetic stimulation and by a decreased vagal tone in cardiovascular disease (CVD).[@b37-ndt-13-2093],[@b38-ndt-13-2093] Earlier studies working with the HRV measurements of the cardiovascular autonomic function showed that individuals with overweight have a substantial decline in the parasympathetic activity and an elevation in sympathetic activity, demonstrating an alteration in the sympathovagal equilibrium to sympathetic predominance.[@b39-ndt-13-2093],[@b40-ndt-13-2093]

Constant variations in sympathetic and parasympathetic impulses on the sinoatrial node show variations in HR and are a source of the oscillations in the R--R interval around its average rate (HRV).[@b28-ndt-13-2093] The obvious approach to quantify the variability of the HR oscillations is linear -- spectral analysis.[@b30-ndt-13-2093] This method is recognized to be a predominantly effective tool in the exploration of autonomic instabilities in numerous disorders.[@b28-ndt-13-2093]--[@b32-ndt-13-2093] The spectral analysis can offer information about functional mechanisms inducing three frequency bands -- the very low frequency (VLF), the low frequency (LF), and the high frequency (HF).[@b28-ndt-13-2093] There are clear suggestions that the HF represents parasympathetic activity, but we must be careful in the explanation of the VLF and LF frequencies.[@b32-ndt-13-2093]

Psychological problems and adverse life events have a role at the beginning of the metabolic syndrome, which is the risk factor for CVDs.[@b41-ndt-13-2093] It is supposed that a higher body weight is associated with clinical CVDs even at moderate degrees as an independent risk factor.[@b42-ndt-13-2093],[@b43-ndt-13-2093] The pathophysiologic mechanisms of cardiovascular dysfunction in obesity have not been fully understood yet, but an autonomic cardiovascular dysregulation has been anticipated as a link connected to the higher body weight and the increased prevalence of heart disease.[@b44-ndt-13-2093]

Higher body weight is possibly related to a clinically relevant cardiovascular illness even at modest degrees of obesity.[@b42-ndt-13-2093],[@b43-ndt-13-2093] Nevertheless, the pathophysiologic mechanisms of the cardiovascular dysfunction in overweight have not yet been completely clarified; the changed autonomic cardiovascular regulation was proposed as a potential mechanism that links overweight with the higher prevalence of heart disease.[@b44-ndt-13-2093]

Study aims
----------

The purpose of this study was to determine which psychological, psychophysiological, and anthropometric factors are connected with life events, level of depression, and quality of life of people with CVD and healthy controls with the following primary hypotheses: Patients with CVDs report more stressful life events, depressive symptoms, and lower quality of life than healthy subjects.Stressful life events in the last 2 years correlate with the quality of life and a level of depressive signs.In healthy volunteers, the stressful life events and depression are linked to the parameters of the autonomic dys-regulation and to the risk factors of the cardiovascular problems, including overweight.In patients with CVD, the stressful life events and depression correlate with being overweight.

Methods
=======

A cross-sectional investigation was used to collect data for an evaluation of the relations between the psychological characteristics and the cardiovascular parameters.

Participants
------------

There were two groups of participants: The first group was recruited from the general population with requirements of the adult age and the absence of a mental disorder or severe cardiovascular disorder both now and in the past.The second group involved patients treated because of arterial hypertension.

Probands were of both sexes, and their age was \>21 years. The participants began to enter the trial in March 2014. The recruitment continued until September 2016.

Study settings
--------------

The probands were measured on the standard conditions in the outpatient cardiology clinic from 8 am to 1 pm. The measurements included an administration of questionnaires, the physical examination, the measurement of BP, anthropological measurements, parameters of the cardiovascular system, and the measurements of psychophysiological functions in relation to mental stress.

Measurements
------------

### Questionnaires

The questionnaires used in the survey were as follows: Social Readjustment Rating Scale (SRRS): this life events questionnaire has 43 items, most of which are taken from Holmes and Rahe's Schedule of Recent Events.[@b45-ndt-13-2093] At a 2-year assessment, the incidence of negative life events since the interview was evaluated with the List of Threatening Events Questionnaire.EuroQol Group 5-Dimension Self-Report Questionnaire (EQ-5D): this is a method used for the evaluation of the quality of life in research in medicine.[@b46-ndt-13-2093] This questionnaire includes five broad domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.[@b47-ndt-13-2093] The additional measure is the EQ-5D visual analog scale (VAS).[@b48-ndt-13-2093],[@b49-ndt-13-2093] EQ-5D is extensively used in various countries in different clinical areas.[@b50-ndt-13-2093] EQ-5D is one of the most frequently used measurements with good validity and reliability.[@b51-ndt-13-2093]Beck Depression Inventory, Second Edition (BDI-II): this inventory describes 21 depressive symptoms. Patients choose which symptoms they perceived in the last 2 weeks and how intense they were.[@b52-ndt-13-2093]--[@b54-ndt-13-2093] Internal consistency of this inventory is higher in the psychiatric population (*α*=0.86) than in the general population (*α*=0.81).[@b54-ndt-13-2093] Preiss and Vaciř[@b55-ndt-13-2093] published the Czech version.

### Physiological measurements

The physiological measurements were as follows: HR: sinus tachycardia was defined as HR per minute.HRV: the changes in the activity of the ANS were measured by the analytic methods using the power spectral analysis of the beat-to-beat interval (R--R interval) sequences that quantify the HRV. HRV was measured for 5 minutes at rest.

The following data were taken and processed by ProComp Infiniti hardware and software (Thought Technology Ltd., Quebec, Canada): Power spectrum was calculated via a fast Fourier transformation for VLF (0.0033--0.04 Hz), LF (0.04--0.15 Hz), and HF (0.15--0.40 Hz) powers.[@b56-ndt-13-2093]--[@b58-ndt-13-2093]Standard deviation of the R--R intervals (SDRR) provided information about total HRV. This measurement shows how much variability exists during a given period, calculated as a standard deviation (SD) of interbeat interval values during a minute. Since the SD is a representation of how spread out the inter beat interval values are, higher SDRR values represent greater variability.HRV total power was the sum of all measured frequencies (VLF + LF + HF).

### Anthropometric characteristics

Basic anthropometric parameters were measured: weight, height, BP, and HR at rest. These parameters were measured in the morning in a fasting state. A trained research nurse was responsible for the measurements of weight, height, BP, and HR at rest in all subjects. All subjects were weighed in light clothing; jackets, coats, and shoes were removed. The weighing measures were calibrated monthly. Height measurements were taken using a specific piece of measuring equipment. The bioimpedance body composition analysis is used to analyze the frequency of the segmental bioimpedance -- the percentage of the body fat, the fat excess above the normal range (fat control). Waist-to-height ratio (WHtR) is defined as the waist perimeter divided by height, both measured in the same units. The WHtR is a measure of the abdominal distribution of body fat. Percentage of body fat (PBF) is the total mass of fat (kg) divided by total body weight (kg) ×100. Fat control is the excess fat above the normal range (kg). Data from arteriography examination: all participants underwent an examination of arterial stiffness using the Arteriograph (TensioMed Ltd., Budapest, Hungry), aortic pulse wave velocity (PWVao), the central systolic blood pressure (SBPao), and the augmentation index (AIx) to measure the risk of atherosclerosis. Endothelial dysfunction is preclinical atherosclerosis in otherwise asymptomatic individuals.[@b59-ndt-13-2093] The risk for CVD determines the stiffness/elasticity of the arteries (PWVao and AIx).[@b59-ndt-13-2093] Electrocardiogram (ECG) and blood volume pulse sensors simultaneously measured HR.Pulse transit time (PTT) is the time required by a pulse wave to leave the heart and reach the site where photoplethysmogram (PPG) is measured. The PTT is the result of calculating the time difference between the r-wave or QRS-complex of the ECG signal and the characteristic p-base point or virtual base point of the PPG signal.[@b60-ndt-13-2093],[@b61-ndt-13-2093] Hey et al[@b60-ndt-13-2093] on their research concluded that PTT seems to be an important major method for the detection of stress. PTT was measured by ProComp Infiniti software version 5.PWVao is determined by the characteristics of the aortic wall and the BP. The stiffer the aorta, the faster the pulse wave. It is measured in meters per second. An optimal speed is less than 7 m/s; the normal one is between 7 and 9.5 m/s. Increased PWVao values are related to the increased cardiovascular risk and the atherosclerotic damage. PWVao is an independent predictor of coronary heart disease and stroke in seemingly healthy subjects and is related to subclinical coronary atherosclerosis independent of the conventional risk factors and may be a biomarker of the cardiovascular risk in asymptomatic individuals.[@b62-ndt-13-2093]SBPao is the central systolic blood pressure. SBPao is normal under 140 mmHg. If the arterial stiffness increases, the SBPao gets higher.[@b59-ndt-13-2093] The non-invasively measured central pulse pressure is related to vascular hypertrophy, the degree of atherosclerosis, and cardiovascular events.[@b63-ndt-13-2093]AIx means the augmentation index (AIx = \[P2-P1/pulse blood pressure\] ×100). AIx determines the sign of arterial stiffening. It is a strong, independent risk marker for premature coronary artery disease.[@b64-ndt-13-2093] AIx is mainly determined by the peripheral arterial resistance of the small arteries and arterioles that are influenced primarily by endothelial NO synthesis. Normal AIx lies below 33%. The values of AIx are usually negative because physiologically P2 has a lower amplitude than P1.[@b59-ndt-13-2093]Other somatic measures The BP is measured in large arteries of the systemic circulation. In our study, the BP was measured on the left and right hands.Thermistor sticks measured temperature (*T*) on the ring finger of the dominant hand. Peripheral skin temperature measurements reflect the blood flow through the vessels under the skin. An increase in the blood flow in the blood vessels results in a higher temperature.

Statistics
----------

Statistics analysis was performed using the statistical software SPSS 24.0 for Windows (IBM Corporation, Armonk, NY, USA) and the Prism (version 5.0; IBM Corporation; <http://www.graphpad.com/prism/prism.htm>). The demographic and clinical data have been computed using column statistics. The Shapiro--Wilk test determined the standard distribution of the demographic and clinical data. Differences between scores or measures were computed by unpaired *t*-tests or Mann--Whitney tests in dichotomous subgroups of data: one-way analysis of variance (ANOVA) or the Kruskal--Wallis test in more than two data categories, according to the type of the data distribution. The Fisher's exact test and chi-square test were used for the categorical variables. Relationships between the variables were analyzed by the Pearson's or Spearman's correlation coefficients, partial correlations using controlled variables of age and sex, and multiple regressions using a backward stepwise regression or a binary logistic regression with the backward logistic regression method. Differences were considered to be significant when *P*-values were \<0.05.

Ethical issues
--------------

The study was carried out in accordance with the latest version of the Declaration of Helsinki and the Guideline for Good Clinical Practice (European Medicines Agency; <http://www.ema.europa.eu/pdfs/human/ich/013595en.pdf>. 20.3.2009). The local ethical committee of the Faculty of Social Science and Health Care, Constantine the Philosopher University in Nitra, approved the study. A written informed consent was obtained from each participant.

Results
=======

Sample description
------------------

This study is a cross-sectional investigation of individuals at the age of 18 years or older. In all, 99 probands were involved in the survey. The average age was 40.5±14.0 years. There were more females (63.6%) than males (36.4%) and higher amount of secondary educated people (51.5%). Most of the participants lived with a partner (94.9%) and were employed (70.7%) or students (16.2%). The majority of the participants were overweight or obese: 24.2% were overweight (n=24), 19.2% were in the obesity class I (n=19), 3.0% were in the obesity class II (n=3), and 3.0% were included in the obesity class III (n=3). There were 8.1% participants who were underweight (n=8), and 36.4% participants had a normal weight (n=36). The participant's characteristics are summarized in [Table 1](#t1-ndt-13-2093){ref-type="table"}.

Comparison of the probands with CVDs and the healthy individuals
----------------------------------------------------------------

There were 54 healthy participants without any history of a mental or physical illness with the mean age of 35.59±13.39 years and 45 patients with CVD (treated for hypertension) with the average age of 46.33±12.39 years. The patients were statistically significantly older than healthy individuals.

The comparison between the healthy people and the patients treated with CVD shows significant differences between the healthy controls and the CVD patients in all measured psychological questionnaires (SRRS, BDI-II, EQ-5D -- VAS, and EQ-5D -- vector), psychophysiological variables (temperature, PTT, HR, LF, HF, and HRV total), anthropological variables (WHtR, PBF, and fat control), and cardiovascular variables (BP, PWVao, SBPao, and AIx; [Table 1](#t1-ndt-13-2093){ref-type="table"}).

The age was significantly correlated with the parameters of ANS SDRR, LF, and HF; body temperature; HRV total; PTT; an anthropometric factor WHtR; and cardiological measures PWVao, SBPao, and AIx ([Table 1](#t1-ndt-13-2093){ref-type="table"}).

Relationship among various psychosocial factors
-----------------------------------------------

A score of the adverse life events according to the SRRS in the whole sample positively correlated with the severity of depressive symptoms assessed by BDI-II and also with the vector of the quality of life measured on an EQ-5D scale, but not with the VAS factor of EQ-5D. The level of depressive symptoms measured by BDI-II positively correlated with both factors of EQ-5D ([Table 2](#t2-ndt-13-2093){ref-type="table"}).

In the control group, there were no correlations between the adverse life events, measured by SRRS, and the severity of depressive symptoms or the quality of life, but there was a correlation between the depression score and both parameters of quality of life.

In the subgroup of patients, there was a highly significant correlation between the stressful life events and the score of depressive symptoms and the EQ-5D -- vector.

Relationship among psychosocial and psychophysiological factors in healthy individuals
--------------------------------------------------------------------------------------

The total score of SRRS on an individual during the last 2 years correlated negatively with HF ([Table 3](#t3-ndt-13-2093){ref-type="table"}). The level of depressive symptoms measured by BDI-II correlated with BP, PBF, fat control, and HRV total ([Table 3](#t3-ndt-13-2093){ref-type="table"}). EQ-5D -- vector did not significantly correlate with any parameters of the ANS activity or anthropometric parameters. EQ-5D -- VAS correlated significantly with body temperature and PBF.

In the group of patients with CVD, the stressful life events score measured by SRRS correlated with WHtR and SBPAo. The level of depressive symptoms measured by BDI-II correlated with PTT and AIx ([Table 4](#t4-ndt-13-2093){ref-type="table"}). EQ-5D -- vector significantly correlated with SDRR, PTT, WHtR, and PBF. EQ-5D -- VAS significantly correlated with WHtR, PBF, and fat control ([Table 4](#t4-ndt-13-2093){ref-type="table"}).

Partial correlations among the psychosocial and psychophysiological measurements after controlling for age and sex
------------------------------------------------------------------------------------------------------------------

Because age and sex had an influence on several cardiovascular and anthropometric characteristics, the next step was the calculation of the partial correlations with the controlling for age and sex ([Tables 5](#t5-ndt-13-2093){ref-type="table"} and [6](#t6-ndt-13-2093){ref-type="table"}).

In the healthy subjects, the SRRS total score was not correlated with any cardiovascular or anthropometric factor. BDI-II significantly correlated with the WHtR, AIx, PBF, and fat control. The quality of life measured by EQ-5D -- vector did not correlate with any cardiovascular or anthropometric factor. The EQ-5D -- VAS correlated with the body temperature, BP, and PBF.

In the group of patients with CVD, SRRS did not correlate with any measured cardiovascular or anthropometric factor, except the WHtR whose correlation was close to the statistically significant level (*P*=0.058). BDI-II significantly correlated with the AIx. EQ-5D -- vector did not correlate with any measured cardiovascular or anthropometric factor. EQ-5D -- VAS significantly correlated with body temperature, WHtR, and fat control ([Table 6](#t6-ndt-13-2093){ref-type="table"}).

Regression analyses
-------------------

A multiple regression analysis with weighting by age was completed to identify the most important factors connected with WHtR and PBF as risk factors for CVDs. The dependent variable was WHtR. Independent variables were temperature, BP, SRRS, BDI-II, EQ-5D -- vector, EQ-5D -- VAS, LF total power, HF total power, and HRV total power. All requested variables were entered. The seven backward stepwise regression phases selected body temperature, BP, and BDI-II, which passed with statistical significance ([Table 7](#t7-ndt-13-2093){ref-type="table"}).

The dependent variable was the sum of PBF. Independent variables were HRV total power, EQ-5D -- VAS, WHtR, BDI-II, and fat control. All requested variables were entered. During the four phases of backward stepwise regression, only BDI-II passed with a statistical significance ([Table 8](#t8-ndt-13-2093){ref-type="table"}).

Discussion
==========

The study intention was to explore if the stressful life events experienced in the past 2 years predict depressive symptoms, quality of life, and psychophysiological and anthropometric aspects connected with increased risk factors for the cardiovascular disorders.

The first hypothesis that "Patients with CVDs report more stressful life events, depressive symptoms, and lower quality of life than healthy subjects" was confirmed. The results are also in agreement with the epidemiological findings that the financial stress, work-related stressful events, diseases and deaths, and stress, in general, had the strongest association with the occurrence of myocardial infarction.[@b65-ndt-13-2093]--[@b67-ndt-13-2093] In addition, there was increased prevalence of hypertension in patients with depressive disorders[@b12-ndt-13-2093],[@b14-ndt-13-2093] and increased frequency of depression in patients with high BP.[@b15-ndt-13-2093] Moreover, also both parameters of quality of life showed higher levels in healthy controls than in patients with CVD. The same outcome was seen in patients with CVD in many studies.[@b68-ndt-13-2093],[@b69-ndt-13-2093]

The second hypothesis that "Stressful life events in the last 2 years correlate with quality of life and a level of depressive symptoms" was not confirmed in our data of the healthy participants, but was confirmed in the patients with CVDs. In the literature, the impact of the stressful life events on the beginning of depression is well documented in the individuals with depression[@b70-ndt-13-2093],[@b71-ndt-13-2093] and also in patients with CVDs.[@b72-ndt-13-2093]--[@b76-ndt-13-2093] Why our healthy control group does not display a relation between the severity of depression and the quality of life is unknown, but it is possible to explain it by the overall low level of the stressful life events in the healthy subject sample, which was significantly less than in the cardiovascular patient's sample.

The third hypothesis that "In healthy volunteers, the stressful life events and depression are linked to the parameters of the autonomic dysregulation and with the risk factors for the cardiovascular problems including overweight" was confirmed partially. No cardiovascular risk factor correlated with the score of stressful life events. However, a higher amount of stressful life events significantly negatively correlated with HF, a possible marker of parasympathetic tone. This means that people who experienced more stressful life events in the last 2 years could display a lower level of parasympathetic tone. There are several findings from other authors that confirm the results of the present study. Our results correspond with the results of the study of Lampert et al[@b73-ndt-13-2093] that showed that total cumulative stress score and cumulative adverse life events were all inversely associated with standard deviation of NN intervals (SDNN), which is linked to the parasympathetic tone. High-frequency variability may be significantly reduced in the patients with depression, indicating that depressive patients have an aberration in the parasympathetic nervous system activity.[@b56-ndt-13-2093],[@b77-ndt-13-2093] The decreased HRV is associated with other CVD risk factors.[@b74-ndt-13-2093] Low HRV is linked to a higher risk of the first cardiovascular incident in people without known CVDs.[@b75-ndt-13-2093]

On the other side, there was no correlation between the level of the symptoms of depression and HF in our sample. Nevertheless, nobody from our probands received a diagnosis of depressive disorders. There was a positive correlation between depressive score and PBF and WHtR (on the border of significance) and a negative correlation with fat control in healthy volunteers. In addition, Harding et al[@b88-ndt-13-2093] described differences in the associations between the psychosocial distress, including the stressful life events, and the changes in body mass index (BMI) during a 5-year period, accentuating the influence of the weight status at the beginning. In addition, Barry and Petry[@b86-ndt-13-2093] presented that overweight/obese women experienced higher level of adverse life events than women with normal weight, whereas, for men, obesity (but not overweight) was connected with more adverse life events.[@b87-ndt-13-2093]--[@b90-ndt-13-2093] Proper et al[@b91-ndt-13-2093] examined the connection between the manifestation, effect, and adaptation to stressful life events and weight changes and the impact of the initial weight. In a population-based cohort of 2,789 adults, they found no proof of a relationship between stressful life events and change in weight of the whole study sample, but they hypothesized that people with normal weight reacted another way to stressful life events than individuals who were overweight.

The fourth hypothesis that "In patients with cardiovascular problems the stressful life events and depression correlate with the overweight" was confirmed. In the sample of the patients with CVDs, the score of stressful life events significantly correlated with WHtR and AIx, which could be independent risk factors for cardiovascular illness and mortality.[@b78-ndt-13-2093] The earlier investigation has shown that stress can induce higher food intake.[@b79-ndt-13-2093]--[@b82-ndt-13-2093] However, it may also suppress eating.[@b81-ndt-13-2093] Dissimilarities in the reactivity to stress lead to alternatives in influence on body weight that could exist between men and women and between the healthy weight and obese adults.[@b79-ndt-13-2093]--[@b82-ndt-13-2093] Based on three prospective studies, it was presented that the impact of distress on the body weight varied according to the initial BMI; positive links were only seen in the overweight people.[@b83-ndt-13-2093]--[@b86-ndt-13-2093] The pathophysiologic mechanisms of cardiovascular dysfunction in obesity have not been fully understood yet, but autonomic cardiovascular dysregulation has been anticipated as a link connecting the higher body weight and the increased prevalence of the heart disease.[@b44-ndt-13-2093] Obese people have an elevation in sympathetic activity and a reduction in parasympathetic modulation of the cardiac function.[@b39-ndt-13-2093],[@b40-ndt-13-2093]

Study limitations
-----------------

The present investigation has some limitations. The main limitation is the number of the probands. The other one is that we were not able to establish the representativeness of the survey sample for adults in Slovakia because of selection biases with the individuals with a higher education who were willing to participate (the participants had only a secondary school or university education; there were no participants with primary education). The future studies should focus on less-educated patients.

The patients with CVD were treated with various medications, mostly antihypertensive, which might have influenced some measured factors, especially findings connected with the autonomic disbalance and metabolism.

A certain bias affects use of the self-evaluation psychosocial assessment methods. The usage of such questionnaires is influenced by the capability of self-reflection of the probands and their willingness to be open in the reports. In addition, several probands did not fulfill the criteria in the forms fully, so they had to be disqualified from some analyses.

Conclusion
==========

Results suggest some possible mechanisms by which stress may exert adversarial effects on cardiovascular morbidity in healthy people. Primary preventive strategies with stress management training may be beneficial. Monitoring this parameter about others even in psychological aspect could be a significant contribution in preventive cardiology.

The outcome has a substantial impact on thinking about the detection of psychological factors in relation to a higher risk of CVDs and could help in planning the psychoeducational and lifestyle changes in the individuals who experience a high level of the stressful life events to decrease the heart disease risk.[@b88-ndt-13-2093]
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Participants' characteristics

  Variables         Whole sample (n=99)   Age correlation coefficient   Healthy people (n=54)   CVD patients (n=45)   *P*-value
  ----------------- --------------------- ----------------------------- ----------------------- --------------------- ---------------------------------------------------------
  Age (years)       40.32±14.01           --                            35.59±13.39             46.33±12.39           Unpaired *t*-test: *t* =4.109, *df* =97; *P*\<0.001
  SRRS              136.30±99.68          0.08                          117.72±93.25            158.47±103.50         Unpaired *t*-test: *t* =2.070, *df* =97; *P*\<0.05
  BDI-II            7.80±8.42             0.18                          5.04±5.97               11.11±9.72            Mann--Whitney test: *U* =662.5; *P*\<0.0001
  EQ-5D -- vector   5.70±2.57             0.16                          5.13±1.02               6.36±3.52             Mann--Whitney test: *U* =692; *P*\<0.005
  EQ-5D -- VAS      77.10±20.11           −0.14                         84.07±16.25             68.73±21.24           Mann--Whitney test: *U* =625; *P*\<0.0001
  HR                72.71±12.93           −0.09                         76.37±13.89             68.33±10.21           Unpaired *t*-test: *t* =3.223, *df* =97; *P*\<0.005
  SDRR              49.44±23.12           −0.27; *P*\<0.01              53.45±22.41             44.61±23.28           Unpaired *t*-test: *t* =1.920, *df* =97; ns (*P*=0.057)
  LF                144.37±177.98         −0.34; *P*\<0.001             177.57±189.89           104.54±155.38         Mann--Whitney test: *U* =721; *P*\<0.0005
  HF                147.72±245.50         −0.29; *P*\<0.005             166.54±278.65           125.13±278.65         Mann--Whitney test: *U* =747; *P*\<0.001
  Temperature       30.89±3.26            0.26; *P*\<0.05               30.07±3.49              31.87±2.67            Unpaired *t*-test: *t* =2.836, *df* =97; *P*\<0.01
  PTT               126.38±59.98          0.23; *P*\<0.05               106.28±42.23            147.81±68.61          Unpaired *t*-test: *t* =3.539, *df* =97; *P*\<0.001
  WHtR              0.49±0.10             0.22; *P*\<0.05               0.44±0.07               0.56±0.09             Unpaired *t*-test: *t* =7.541, *df* =95; *P*\<0.0001
  BP                70.29±11.63           0.09                          67.09±8.24              74.13±13.86           Mann--Whitney test: *U* =605; *P*\<0.0001
  Pulse/min         70.63±11.92           −0.01                         70.54±11.13             70.76±10.78           Unpaired *t*-test: *t* =0.0987, *df* =97; ns
  PWVao             8.23±2.14             0.35; *P*\<0.001              7.41±1.89               9.26±2.01             Mann--Whitney test: *U* =424.5; *P*\<0.0001
  SBPao             127.56±25.46          0.39; *P*\<0.0001             116.19±21.76            141.77±22.61          Unpaired *t*-test: *t* =5.445, *df* =88; *P*\<0.0001
  AIx               −29.08±32.05          0.36; *P*\<0.001              −44.10±23.82            −10.30±31.31          Unpaired *t*-test: *t* =5.816, *df* =88; *P*\<0.0001
  PBF               26.34±10.45           0.18                          22.12±8.65              31.53±10.20           Unpaired *t*-test: *t* =4.944, *df* =96; *P*\<0.0001
  Fat control       −8.56±12.95           −0.17                         −2.71±7.05              −15.94±14.78          Mann--Whitney test: *U* =411.5; *P*\<0.0001
  HRV total power   365.09±429.06         −0.32; *P*\<0.005             434.99±411.58           281.22±438.07         Mann--Whitney test: *U* =664; *P*\<0.0001

**Notes:** Fat control, the fat excess above the normal range (kg); HRV total power, the sum of all measured frequencies (VLF + LF + HF). Data presented as mean ± SD.

**Abbreviations:** CVD, cardiovascular disease; SRRS, Social Readjustment Rating Scale; BDI-II, Beck Depression Inventory, Second Edition; EQ-5D --vector, EuroQol Group 5-Dimension Self-Report Questionnaire -- vector; EQ-5D -- VAS, EuroQol Group 5-Dimension Self-Report Questionnaire -- visual analog scale; HR, heart rate; SDRR, standard deviation of R--R intervals; ns, not significant; LF, low frequency; HF, high frequency; PTT, pulse transit time; WHtR, waist-to-height ratio; BP, blood pressure; PWVao, aortic pulse wave velocity; SBPao, central systolic blood pressure; AIx, augmentation index; PBF, percent of body fat; HRV, heart rate variability; VLF, very low frequency.

###### 

Correlation between stressful life events, depressive symptoms, and the quality of life

  Parameters           BDI-II                                                                                           EQ-5D -- vector                                                                                    EQ-5D -- VAS
  -------------------- ------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------
  Whole sample                                                                                                                                                                                                             
   SRRS                0.33[S](#tfn4-ndt-13-2093){ref-type="table-fn"},[\*\*](#tfn6-ndt-13-2093){ref-type="table-fn"}   0.33[S](#tfn4-ndt-13-2093){ref-type="table-fn"},[\*\*](#tfn6-ndt-13-2093){ref-type="table-fn"}     −0.20
   BDI-II              --                                                                                               0.48[S](#tfn4-ndt-13-2093){ref-type="table-fn"},[\*\*\*](#tfn7-ndt-13-2093){ref-type="table-fn"}   −0.47[S](#tfn4-ndt-13-2093){ref-type="table-fn"},[\*\*\*](#tfn7-ndt-13-2093){ref-type="table-fn"}
   EQ-5D -- vector     --                                                                                               --                                                                                                 −0.38[S](#tfn4-ndt-13-2093){ref-type="table-fn"},[\*\*\*](#tfn7-ndt-13-2093){ref-type="table-fn"}
  Healthy persons                                                                                                                                                                                                          
   SRRS                0.25                                                                                             0.27[S](#tfn4-ndt-13-2093){ref-type="table-fn"}^,\ ns\ (*P*=0.06)^                                 −0.16
   BDI-II              --                                                                                               0.45[S](#tfn4-ndt-13-2093){ref-type="table-fn"},[\*\*\*](#tfn7-ndt-13-2093){ref-type="table-fn"}   −0.27[S](#tfn4-ndt-13-2093){ref-type="table-fn"},[\*](#tfn5-ndt-13-2093){ref-type="table-fn"}
   EQ-5D -- vector     --                                                                                               --                                                                                                 −0.19
  Patients with CVDs                                                                                                                                                                                                       
   SRRS                0.60[P](#tfn3-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.0001^                                  0.32[S](#tfn4-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^                                      −0.29[P](#tfn3-ndt-13-2093){ref-type="table-fn"}^,\ ns\ (*P*=−0.050)^
   BDI-II              --                                                                                               0.19                                                                                               −0.23
   EQ-5D -- vector     --                                                                                               --                                                                                                 −0.40[S](#tfn4-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.01^

**Notes:**

Pearson's *r*;

Spearman's *r*;

*P*\<0.05,

*P*\<0.01, and

*P*\<0.001.

**Abbreviations:** BDI-II, Beck Depression Inventory, Second Edition; EQ-5D -- vector, EuroQol Group 5-Dimension Self-Report Questionnaire -- vector; EQ-5D -- VAS, EuroQol Group 5-Dimension Self-Report Questionnaire -- visual analog scale; SRRS, Social Readjustment Rating Scale; ns, not significant.

###### 

Correlation among psychosocial and psychophysiological measurements in healthy subjects

  Parameters        SRRS                                                             BDI-II                                                               EQ-5D -- vector   EQ-5D -- VAS
  ----------------- ---------------------------------------------------------------- -------------------------------------------------------------------- ----------------- ----------------------------------------------------------------
  HR                0.12                                                             −0.16                                                                −0.10             −0.07
  SDRR              −0.16                                                            −0.19                                                                −0.18             0.05
  LF                −0.03                                                            −0.22                                                                −0.17             0.07
  HF                −0.27[S](#tfn9-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^   −0.23                                                                −0.25             0.09
  Temperature       0.18                                                             −0.04                                                                0.13              0.32[S](#tfn9-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^
  PTT               0.01                                                             −0.14                                                                0.19              −0.25
  WHtR              0.09                                                             0.27[S](#tfn9-ndt-13-2093){ref-type="table-fn"}^,\ ns\ (*P*=0.54)^   0.13              0.03
  BP                0.05                                                             0.28[S](#tfn9-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^        −0.05             −0.25
  PWVao             0.04                                                             −0.09                                                                −0.04             0.02
  SBPao             0.01                                                             −0.12                                                                0.16              −0.06
  AIx               0.02                                                             0.11                                                                 0.06              −0.19
  PBF               0.07                                                             0.27[S](#tfn9-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^        0.09              −0.31[S](#tfn9-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^
  Fat control       −0.10                                                            −0.30[S](#tfn9-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^       −0.21             0.04
  HRV total power   −0.18                                                            −0.32[S](#tfn9-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^       −0.14             0.14

**Notes:**

Spearman's *r*; fat control, the fat excess above the normal range (kg); and HRV total power, the sum of all measured frequencies (VLF + LF + HF).

**Abbreviations:** SRRS, Social Readjustment Rating Scale; BDI-II, Beck Depression Inventory, Second Edition; EQ-5D -- vector, EuroQol Group 5-Dimension Self-Report Questionnaire -- vector; EQ-5D -- VAS, EuroQol Group 5-Dimension Self-Report Questionnaire -- visual analog scale; HR, heart rate; SDRR, standard deviation of R--R intervals; LF, low frequency; HF, high frequency; PTT, pulse transit time; WHtR, waist-to-height ratio; ns, not significant; BP, blood pressure; PWVao, aortic pulse wave velocity; SBPao, central aortic blood pressure; AIx, augmentation index; PBF, percent of body fat; HRV, heart rate variability; VLF, very low frequency; ns, not significant.

###### 

Correlation among psychosocial and psychophysiological measurements in the patients with CVDs

  Parameters        SRRS                                                              BDI-II                                                                 EQ-5D -- vector                                                          EQ-5D -- VAS
  ----------------- ----------------------------------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------------------ ----------------------------------------------------------------------
  HR                0.09                                                              0.13                                                                   −0.09                                                                    −0.16
  SDRR              −0.04                                                             0.07                                                                   −0.31[S](#tfn12-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^          0.02
  LF                0.06                                                              0.14                                                                   −0.22                                                                    −0.02
  HF                −0.10                                                             −0.06                                                                  −0.27                                                                    −0.13
  Temperature       −0.02                                                             −0.20                                                                  0.27                                                                     −0.16
  PTT               −0.22                                                             −0.35[P](#tfn11-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^        −0.36[S](#tfn12-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^          0.29[P](#tfn11-ndt-13-2093){ref-type="table-fn"}^,\ ns\ (*P*=0.056)^
  WHtR              0.38[P](#tfn11-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.01^    0.29[P](#tfn11-ndt-13-2093){ref-type="table-fn"}^,\ ns\ (*P*=0.053)^   0.39[S](#tfn12-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.01^           −0.41[P](#tfn11-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.005^
  BP                −0.11                                                             −0.11                                                                  0.01                                                                     −0.20
  PWVao             −0.07                                                             −0.08                                                                  0.07                                                                     0.07
  SBPao             0.03                                                              −0.17                                                                  0.03                                                                     −0.02
  AIx               −0.38[P](#tfn11-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^   −0.44[P](#tfn11-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.01^        −0.08                                                                    0.07
  PBF               0.14                                                              0.15                                                                   0.45[S](#tfn12-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.01^           −0.33[P](#tfn11-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.05^
  Fat control       −0.27                                                             −0.19                                                                  −0.46[S](#tfn12-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.005^         0.50[P](#tfn11-ndt-13-2093){ref-type="table-fn"}^,\ *P*\<0.0005^
  HRV total power   0.01                                                              0.05                                                                   −0.29[S](#tfn12-ndt-13-2093){ref-type="table-fn"}, ^ns\ (*P*\<0.0505)^   −0.09

**Notes:**

Pearson's *r*;

Spearman's *r*; fat control, the fat excess above the normal range (kg); HRV total power, the sum of all measured frequencies (VLF + LF + HF).

**Abbreviations:** CVD, cardiovascular disease; SRRS, Social Readjustment Rating Scale; BDI-II, Beck Depression Inventory, Second Edition; EQ-5D --vector, EuroQol Group 5-Dimension Self-Report Questionnaire -- vector; EQ-5D -- VAS, EuroQol Group 5-Dimension Self-Report Questionnaire -- visual analog scale; HR, heart rate; SDRR, standard deviation of R--R intervals; LF, low frequency; HF, high frequency; PTT, pulse transit time; ns, not significant; WHtR, waist-to-height ratio; BP, blood pressure; PWVao, aortic pulse wave velocity; SBPao, central aortic blood pressure; AIx, augmentation index; PBF, percent of body fat; HRV, heart rate variability; VLF, very low frequency.

###### 

Partial correlation among psychosocial and psychophysiological measurements after controlling for age and sex in healthy subjects

  Parameters        SRRS    BDI-II               EQ-5D -- vector   EQ-5D -- VAS
  ----------------- ------- -------------------- ----------------- ------------------
  HR                0.16    −0.15                −0.02             0.08
  SDRR              −0.16   −0.26                −0.20             0.15
  LF                0.07    −0.23                −0.10             0.17
  HF                −0.21   −0.28                −0.18             0.17
  Temperature       0.15    −0.20                −0.06             0.32^*P*\<0.05^
  PTT               0.00    0.03                 −0.03             −0.27
  WHtR              0.12    0.31^*P*\<0.05^      0.11              −0.12
  BP                −0.01   0.18                 −0.05             −0.34^*P*\<0.05^
  PWVao             0.08    −0.01                0.07              0.08
  SBPao             0.05    0.06                 0.11              0.09
  AIx               0.03    0.32^*P*\<0.05^      0.03              −0.29
  PBF               0.07    0.40^*P*\<0.05^      0.02              −0.37^*P*\<0.05^
  Fat control       −0.15   −0.42*^P^*^\<0.01^   −0.18             0.25
  HRV total power   −0.07   −0.26                −0.15             0.21

**Notes:** Fat control, the fat excess above the normal range (kg); HRV total power, the sum of all measured frequencies (VLF + LF + HF).

**Abbreviations:** SRRS, Social Readjustment Rating Scale; BDI-II, Beck Depression Inventory, Second Edition; EQ-5D -- vector, EuroQol Group 5-Dimension Self-Report Questionnaire -- vector; EQ-5D -- VAS, EuroQol Group 5-Dimension Self-Report Questionnaire -- visual analog scale; HR, heart rate; SDRR, standard deviation of R--R intervals; LF, low frequency; HF, high frequency; PTT, pulse transit time; WHtR, waist-to-height ratio; BP, blood pressure; PWVao, aortic pulse wave velocity; SBPao, central aortic blood pressure; AIx, augmentation index; PBF, percent of body fat; HRV, heart rate variability; VLF, very low frequency.

###### 

Partial correlation among psychosocial and psychophysiological measurements after controlling for age and sex in patients with cardiovascular disease

  Parameters        SRRS                        BDI-II             EQ-5D -- vector   EQ-5D -- VAS
  ----------------- --------------------------- ------------------ ----------------- ------------------
  HR                0.06                        0.11               −0.16             0.02
  SDRR              0.09                        0.12               −0.17             −0.02
  LF                0.09                        0.11               −0.14             −0.08
  HF                0.13                        0.09               −0.09             −0.07
  Temperature       −0.12                       −0.24              0.15              −0.38^*P*\<0.05^
  PTT               −0.15                       −0.30              0.01              0.27
  WHtR              0.32^ns\ (^*^P^*^=0.058)^   0.32               0.15              −0.43^*P*\<0.05^
  BP                0.08                        0.16               0.02              −0.22
  PWVao             0.03                        −0.06              0.02              −0.03
  SBPao             0.09                        −0.09              0.09              −0.16
  AIx               −0.26                       −0.35^*P*\<0.05^   0.09              0.10
  PBF               0.13                        0.09               0.23              −0.25
  Fat control       −0.28                       −0.24              −0.17             0.36^*P*\<0.05^
  HRV total power   0.14                        0.12               −0.13             −0.08

**Notes:** Fat control, the fat excess above the normal range (kg); HRV total power, the sum of all measured frequencies (VLF + LF + HF).

**Abbreviations:** SRRS, Social Readjustment Rating Scale; BDI-II, Beck Depression Inventory, Second Edition; EQ-5D -- vector, EuroQol Group 5-Dimension Self-Report Questionnaire -- vector; EQ-5D -- VAS, EuroQol Group 5-Dimension Self-Report Questionnaire -- visual analog scale; HR, heart rate; SDRR, standard deviation of R--R intervals; LF, low frequency; HF, high frequency; PTT, pulse transit time; WHtR, waist-to-height ratio; ns, not significant; BP, blood pressure; PWVao, aortic pulse wave velocity; SBPao, central aortic blood pressure; AIx, augmentation index; PBF, percent of body fat; HRV, heart rate variability; VLF, very low frequency.

###### 

Multiple regression analysis of WHtR as a dependent variable

  Regressors         *B*     SE      *β*     *t*     Significance
  ------------------ ------- ------- ------- ------- --------------
  Body temperature   0.006   0.003   0.302   2.397   0.021
  BP                 0.002   0.001   0.250   1.955   0.057
  BDI-II             0.004   0.001   0.374   3.009   0.004

**Note:** ANOVA: *F*=81.81, *df* =51, *P*\<0.000, and adjusted *r*^2^=0.29.

**Abbreviations:** WHtR, waist-to-height ratio; *B*, unstandardized coefficient; SE, standard error; *β*, standardized coefficient; *t*, *t*-statistic; BP, blood pressure; BDI-II, Beck Depression Inventory, Second Edition; ANOVA, analysis of variance.

###### 

Multiple regression analysis of PBF as a dependent variable

  Regressors     *B*      SE      *β*      *t*      Significance
  -------------- -------- ------- -------- -------- --------------
  BDI-II         0.594    0.200   0.380    2.978    0.005
  EQ-5D -- VAS   −0.147   0.074   −0.253   −1.987   0.053

**Note:** ANOVA: *F*=7.54, *df* =51, *P*\<0.001, and adjusted *r*^2^=0.21.

**Abbreviations:** PBF, percentage of body fat; B, unstandardized coefficient; SE, standard error; *β*, standardized coefficient; *t*, *t*-statistic; BDI-II, Beck Depression Inventory, Second Edition; EQ-5D -- VAS, EuroQol Group 5-Dimension Self-Report Questionnaire -- visual analog scale; ANOVA, analysis of variance.
